Arabia Saudí - inglés - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

panacea biotec pharma ltd, india - rizatriptan benzoate - orodispersible tablet - 10 mg,

Arabia Saudí - inglés - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

panacea biotec pharma ltd, india - rizatriptan benzoate - orodispersible tablet - 5 mg,

Arabia Saudí - inglés - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

panacea biotec pharma ltd, india - cyclosporin - capsule, hard - 25 mg,

Tanzania - inglés - Tanzania Medicinces & Medical Devices Authority

panacea biotec pharma limited (unit-1), india - aceclofenac - tablets - 200

Nigeria - inglés - NAFDAC (National Agency for Food and Drugs Administration and Control)

panacea biotech - tacrolimus 0.5mg

Nigeria - inglés - NAFDAC (National Agency for Food and Drugs Administration and Control)

panacea biotech - tacrolimus 1mg

Nigeria - inglés - NAFDAC (National Agency for Food and Drugs Administration and Control)

panacea biotech - tacrolimus 5mg

Estados Unidos - inglés - NLM (National Library of Medicine)

panacea biotec limited - tacrolimus (unii: wm0haq4wnm) (tacrolimus anhydrous - unii:y5l2157c4j) - tacrolimus anhydrous 0.5 mg - tacrolimus capsules is indicated for the prophylaxis of organ rejection, in patients receiving allogeneic kidney transplant  [see clinical studies ( 14.1)] , liver transplants  [see clinical studies ( 14.2)]  and heart transplant  [see clinical studies ( 14.3)] , in combination with other immunosuppressants. tacrolimus capsules are contraindicated in patients with a hypersensitivity to tacrolimus. tacrolimus injection is contraindicated in patients with a hypersensitivity to hco-60 (polyoxyl 60 hydrogenated castor oil). hypersensitivity symptoms reported include dyspnea, rash, pruritus, and acute respiratory distress syndrome [see adverse reactions ( 6)] . pregnancy exposure registry there is a pregnancy registry that monitors pregnancy outcomes in women exposed to tacrolimus during pregnancy. the transplantation pregnancy registry

Canadá - inglés - Health Canada

panacea biotec pharma limited - paclitaxel - powder for suspension - 100mg - paclitaxel 100mg

Estados Unidos - inglés - NLM (National Library of Medicine)

panacea biotec limited - rizatriptan benzoate (unii: wr978s7qhh) (rizatriptan - unii:51086hbw8g) - rizatriptan 5 mg - rizatriptan benzoate orally disintegrating tablets are indicated for the acute treatment of migraine with or without aura in adults and in pediatric patients 6 to 17 years old. limitations of use - rizatriptan benzoate orally disintegrating tablets should only be used where a clear diagnosis of migraine has been established. if a patient has no response for the first migraine attack treated with rizatriptan benzoate orally disintegrating tablets, usp, the diagnosis of migraine should be reconsidered before rizatriptan benzoate orally disintegrating tablets, usp are administered to treat any subsequent attacks. - rizatriptan benzoate orally disintegrating tablets are not indicated for use in the management of hemiplegic or basilar migraine [see  contraindications (4)] . - rizatriptan benzoate orally disintegrating tablets are not indicated for the prevention of migraine attacks. - safety and effectiv